Enterocolitis, Pseudomembranous
"Enterocolitis, Pseudomembranous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.
| Descriptor ID |
D004761
|
| MeSH Number(s) |
C01.252.410.222.310 C06.405.205.596.800 C06.405.469.363.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Enterocolitis, Pseudomembranous".
Below are MeSH descriptors whose meaning is more specific than "Enterocolitis, Pseudomembranous".
This graph shows the total number of publications written about "Enterocolitis, Pseudomembranous" by people in this website by year, and whether "Enterocolitis, Pseudomembranous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Enterocolitis, Pseudomembranous" by people in Profiles.
-
Yoshikawa TT, Norman DC. Geriatric Infectious Diseases: Current Concepts on Diagnosis and Management. J Am Geriatr Soc. 2017 Mar; 65(3):631-641.
-
Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother. 2016 06; 60(6):3717-29.
-
Tsutsumi LS, Owusu YB, Hurdle JG, Sun D. Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. Curr Top Med Chem. 2014; 14(1):152-75.
-
Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010 Jul; 105(7):1636-41.
-
Akhtar AJ, Shaheen M. Increasing incidence of clostridium difficile-associated diarrhea in African-American and Hispanic patients: association with the use of proton pump inhibitor therapy. J Natl Med Assoc. 2007 May; 99(5):500-4.
-
Furrie E, Senok AC, Frank DN, Sullivan KE. Pondering probiotics. Clin Immunol. 2006 Oct; 121(1):19-22.